Literature DB >> 16476643

Healthcare workers who elected not to receive smallpox vaccination.

Pascale M Wortley1, Benjamin Schwartz, Paul S Levy, Linda M Quick, Brian Evans, Brian Burke.   

Abstract

BACKGROUND: The goal of the National Smallpox Vaccination Program was to vaccinate a cadre of healthcare workers and first responders who could care for smallpox patients in the event of an attack.
METHODS: Using a convenience sample of health departments (n=49) and hospitals (n=60) in five states, we conducted a telephone interview between July 2003 and April 2004 of healthcare workers and first responders who chose not to receive smallpox vaccination. (Data were analyzed in 2004 and 2005.)
RESULTS: The response rate was 63%. Of 1895 respondents, 723 (38.2%) reported having a contraindication, 280 (14.8%) reported being contraindicated because of a household member's condition, and 892 (47.0%) reported having no contraindication to smallpox vaccination. Among respondents with no contraindication, the leading reasons for nonvaccination were concerns about side effects (20.6%) and not feeling that the risk of outbreak was high enough (19.5%). More than half (54.8%) were somewhat or very concerned about having an adverse reaction to the vaccine; Hispanics, blacks, and Asians were significantly more likely than whites to be somewhat or very concerned about side effects. Less than one fifth (17.9%) reported that there was a policy to financially compensate employees who developed side effects from vaccination, and 40.7% reported that there was a policy to provide liability coverage to employees who transmitted vaccinia to a patient.
CONCLUSIONS: Many people who chose not to receive smallpox vaccine perceived their personal risk-benefit balance as not favoring vaccination. The success of future smallpox vaccination efforts or vaccination against other bioterrorist health threats depends on addressing potential barriers to participation including compensation and liability issues, in addition to clearly communicating risks and benefits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476643     DOI: 10.1016/j.amepre.2005.10.005

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  5 in total

1.  The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.

Authors:  Hajime Sato; Jun Tomio; Yoshiaki Tanaka; Emiko Iwasaki
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

Review 2.  Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.

Authors:  Hajime Sato
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

Review 3.  The social, political, ethical, and economic aspects of biodefense vaccines.

Authors:  Gregory A Poland; Robert M Jacobson; Jon Tilburt; Kristin Nichol
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

4.  Neurologic adverse events associated with smallpox vaccination in the United States--response and comment on reporting of headaches as adverse events after smallpox vaccination among military and civilian personnel.

Authors:  Walter R Schumm
Journal:  BMC Med       Date:  2006-11-10       Impact factor: 8.775

5.  Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.

Authors:  J Mauricio Calvo-Calle; Iwona Strug; Maria-Dorothea Nastke; Stephen P Baker; Lawrence J Stern
Journal:  PLoS Pathog       Date:  2007-10-12       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.